- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Ocugen is a biotechnology business based in the US. Ocugen shares (OCGN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.86 – a decrease of 1.45% over the previous week. Ocugen employs 65 staff and has a trailing 12-month revenue of around $4.7 million.
Our top picks for where to buy Ocugen stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Ocugen stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OCGN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Ocugen stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Ocugen stock price (NASDAQ: OCGN)
Use our graph to track the performance of OCGN stocks over time.Ocugen shares at a glance
Information last updated 2024-12-12.
| Latest market close | $0.86 |
|---|---|
| 52-week range | $0.37 - $2.11 |
| 50-day moving average | $0.95 |
| 200-day moving average | $1.30 |
| Wall St. target price | $6.25 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.19 |
Is it a good time to buy Ocugen stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ocugen price performance over time
Historical closes compared with the close of $0.8574 from 2024-12-13
| 1 week (2024-12-06) | -1.45% |
|---|---|
| 1 month (2024-11-15) | -8.65% |
| 3 months (2024-09-13) | -29.14% |
| 6 months (2024-06-14) | -39.62% |
| 1 year (2023-12-15) | 126.83% |
|---|---|
| 2 years (2022-12-15) | -40.87% |
| 3 years (2021-12-15) | 5.42 |
| 5 years (2019-12-13) | 152.18% |
Ocugen financials
| Revenue TTM | $4.7 million |
|---|---|
| Gross profit TTM | $-49,757,000 |
| Return on assets TTM | -47.98% |
| Return on equity TTM | -103.29% |
| Profit margin | 0% |
| Book value | $0.16 |
| Market Capitalization | $253.4 million |
TTM: trailing 12 months
Ocugen share dividends
We're not expecting Ocugen to pay a dividend over the next 12 months.
Have Ocugen's shares ever split?
Ocugen's shares were split on a 1:60 basis on 29 September 2019 . So if you had owned 60 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ocugen shares – just the quantity. However, indirectly, the new 5900% higher share price could have impacted the market appetite for Ocugen shares which in turn could have impacted Ocugen's share price.
Ocugen share price volatility
Over the last 12 months, Ocugen's shares have ranged in value from as little as $0.37 up to $2.105. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ocugen's is 3.766. This would suggest that Ocugen's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Ocugen overview
Ocugen, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates.
Frequently asked questions
What percentage of Ocugen is owned by insiders or institutions?Currently 1.407% of Ocugen shares are held by insiders and 27.528% by institutions. How many people work for Ocugen?
Latest data suggests 65 work at Ocugen. When does the fiscal year end for Ocugen?
Ocugen's fiscal year ends in December. Where is Ocugen based?
Ocugen's address is: 11 Great Valley Parkway, Malvern, PA, United States, 19355 What is Ocugen's ISIN number?
Ocugen's international securities identification number is: US67577C1053 What is Ocugen's CUSIP number?
Ocugen's Committee on Uniform Securities Identification Procedures number is: 67577C105
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question